https://www.marketscreener.com/quote/stock/NGM-BIOPHARMACEUTICALS-IN-56727727/news/NGM-Biopharmaceuticals-Inc-Presents-Positive-Phase-2b-Results-from-the-Alpha-4-Trial-of-Aldafermin-45317738/?utm_source=telegram&utm_medium=social&utm_campaign=share